Tower Research Capital LLC (Trc) Repare Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 34,423 shares of RPTX stock, worth $43,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,423
Previous 11,296
204.74%
Holding current value
$43,372
Previous $38,000
18.42%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$13 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.34 Million1.93% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.19 Million0.12% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.74 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.33 Million5.13% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $52.8M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...